Unlock instant, AI-driven research and patent intelligence for your innovation.
Tibetan medicine composition used for viral pneumonia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of viral pneumonia and composition, applied in the field of medicine, can solve the problems of large toxic and side effects, low cure rate and the like
Inactive Publication Date: 2017-07-04
SHANDONG JINHE DRUG RES DEV
View PDF2 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Most of the existing therapeutic drugs are antiviral agents, antibiotics or hormones, which have great toxic and side effects on the human body and a low cure rate
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
experiment example 1
[0039] Experimental example 1, anti-influenza virus pneumonia pharmacodynamics experiment
[0040] 1. Experimental materials
[0041] Viruses: Type A H1N1, H2N2, H5N1 and Type B influenza viruses, cited from Institute of Virology, Chinese Academy of Preventive Medicine. After recovery, the virus amplifies and multiplies in the allantoic cavity of healthy fertilized chicken eggs and mice, and is stored at -80°C for later use.
[0042] Animals: BALB / c mice, 5-7 weeks old, half male and half female, body weight 12±2g, SPF grade, provided by Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. Animal certificate number: SCXK (Beijing) 2012— 2013.
[0045] Add water to decoct all the medicinal materials twice, add 10 times the amount of water for the first time, ...
experiment example 2
[0078] Experimental example 2, the effect of medicine of the present invention on respiratory syncytial virus pneumonia in vivo
[0079] 1. Experimental materials
[0080] The virus species Respiratory syncytial virus (RSV) Long strain was quoted from the Virus Laboratory of the Institute of Virology, Chinese Academy of Preventive Medicine, and the human laryngeal carcinomacell line (Hep-2 cells), provided by the Microbiology Laboratory of the Basic Institute of Shandong Academy of Medical Sciences; BALB / c mice , 5-7 weeks, half male and half male, body weight 12±1g, SPF grade, cited from Shandong University Animal Center, SPF grade animal license number: SCXX (Lu) 2013004; Ribavirin, Yantai No. 2 Pharmaceutical Factory, batch number 20140617 . The drug preparation is the same as in Experimental Example 1.
[0083] Use Hep-2 cellmonolayer culture, inoculate 7 concentrations of 10-fold diluted ...
Embodiment 1
[0104] Embodiment 1, a kind of Tibetan medicine composition for viral pneumonia, the composition is as follows: Gentiana chinensis 33g, crab carapace 48g, myrobalan 50g, sandalwood 11g, rock cabbage 30g, clove 11g, ditch grass 31g, big flower gentian 9g and fenugreek 10g are used for the preparation of medicines for treating H1N1 viral pneumonia.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a Tibetan medicine composition used for viral pneumonia. Results of animal experiments show that high dose of the Tibetan medicine composition enables the inhibition rate of the lung index of a mouse with pneumonia caused by influenza A H1N1 viruses, influenza A H2N2 viruses, influenza A H5N1 viruses, influenza B viruses and respiratory syncytial viruses (RSVs) to be greater than 40%; the lung index of a model mouse having taken the composition has no significant difference compared with the lung index of a normal mouse from a control group; medium dose and low dose of the composition also have substantial inhibitory effect, with the inhibition rates both greater than 15%; the Tibetan medicine composition can substantially reduce the mortality of mice caused by infection with RSVs and substantially resist reduction in the spleen indexes and thymus indexes of mice infected with RSVs; and the Tibetan medicine composition can substantially improve the immunologic functions of mice with RSV viral pneumonia and reduce the mortality of the mice.
Description
technical field [0001] The invention relates to a Tibetan medicine composition for viral pneumonia, which belongs to the field of medicine. Background technique [0002] At present, the pathogenic status of viruses in pneumonia has attracted more and more attention. In particular, the emergence of coronavirus, avian influenza virus A (H5N1), and pandemic influenza virus A (H1N1) has once again aroused people's attention to severe pneumonia caused by respiratory virus infection. The incidence of viral pneumonia and the aggravation of its symptoms. It is estimated that about 4 million people die from viral pneumonia every year in the world. This disease has become the third leading cause of death after ischemic heartdisease and cerebrovascular disease. The demand for drugs to relieve and treat this disease is increasing Big. [0003] Viral pneumonia is caused by adenovirus, respiratory syncytial virus, influenza virus, parainfluenza virus, Coxsackie virus, echovirus, etc. ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More